- Home
- CCRD vs ACRS Comparison
CCRD vs ACRS Comparison
Compare CCRD & ACRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCRD
- ACRS
- Stock Information
- Founded
- CCRD 1973
- ACRS 2012
- Country
- CCRD United States
- ACRS United States
- Employees
- CCRD N/A
- ACRS N/A
- Industry
- CCRD
- ACRS Biotechnology: Pharmaceutical Preparations
- Sector
- CCRD
- ACRS Health Care
- Exchange
- CCRD Nasdaq
- ACRS Nasdaq
- Market Cap
- CCRD 157.9M
- ACRS 165.7M
- IPO Year
- CCRD N/A
- ACRS 2015
- Fundamental
- Price
- CCRD $26.31
- ACRS $1.53
- Analyst Decision
- CCRD Hold
- ACRS Strong Buy
- Analyst Count
- CCRD 1
- ACRS 9
- Target Price
- CCRD $21.00
- ACRS $9.25
- AVG Volume (30 Days)
- CCRD 54.1K
- ACRS 1.3M
- Earning Date
- CCRD 08-04-2025
- ACRS 08-06-2025
- Dividend Yield
- CCRD N/A
- ACRS N/A
- EPS Growth
- CCRD 187.14
- ACRS N/A
- EPS
- CCRD 0.86
- ACRS N/A
- Revenue
- CCRD $61,011,000.00
- ACRS $17,777,000.00
- Revenue This Year
- CCRD $17.35
- ACRS N/A
- Revenue Next Year
- CCRD N/A
- ACRS $8.11
- P/E Ratio
- CCRD $30.61
- ACRS N/A
- Revenue Growth
- CCRD 12.31
- ACRS N/A
- 52 Week Low
- CCRD $11.57
- ACRS $1.05
- 52 Week High
- CCRD $31.99
- ACRS $5.17
- Technical
- Relative Strength Index (RSI)
- CCRD 41.61
- ACRS 47.05
- Support Level
- CCRD $25.65
- ACRS $1.51
- Resistance Level
- CCRD $29.40
- ACRS $1.76
- Average True Range (ATR)
- CCRD 1.32
- ACRS 0.12
- MACD
- CCRD -0.31
- ACRS -0.01
- Stochastic Oscillator
- CCRD 17.60
- ACRS 8.35
About CCRD CoreCard Corporation
CoreCard Corp is engaged in the business of providing technology solutions and processing services to the financial technology and services market. It designs, develops and markets a comprehensive suite of software solutions to program managers, accounts receivable businesses, financial institutions, retailers and processors to manage their credit and debit cards, prepaid cards, private label cards, fleet cards, buy now pay later programs, loyalty programs and accounts receivable and loan transactions. The CoreCard software platform and modules include CoreENGINE, CoreISSUE, CoreFRAUD, CoreCOLLECT, CoreAPP, CoreMONEY and CoreACQUIRE. Its customers are located in the U.S, European Union and the Middle East of which key revenue is derived from the U.S.
About ACRS Aclaris Therapeutics Inc.
Aclaris Therapeutics Inc is a clinical-stage biopharmaceutical company that operates in the United States. It focuses on developing novel drug candidates for immuno-inflammatory diseases. The company operates in two reportable segments: therapeutics and contract research. The therapeutics segment is focused on identifying and developing inventive therapies to address unmet needs for immuno-inflammatory diseases, and the contract research segment is engaged in providing laboratory services. A majority of the company's revenue is derived from the therapeutics segment. The various drug candidates in its product pipeline are Zunsemetinib, which is an Oral MK2 Inhibitor; ATI-2138, an ITJ Inhibitor; Bosakitug, ATI-052, and Lepzacitinib.